maxent3 algorithm (Waters Corporation)
86
Structured Review
Waters Corporation
maxent3 algorithm
Maxent3 Algorithm, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/maxent3+algorithm/pmc08084162-150-24-26
Average 86 stars, based on 1 article reviews
Maxent3 Algorithm, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/maxent3+algorithm/pmc08084162-150-24-26
Average 86 stars, based on 1 article reviews
maxent3 algorithm - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
Software:Article Title: CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody Article Snippet: .. Mass Spectra were deconvoluted using the Targeted Proteomics:Article Title: Arsenite Exposure Displaces Zinc from ZRANB2 Leading to Altered Splicing Article Snippet: Data were acquired on the Synapt G2-Si Q-Tof (Waters Corp.) using the scan range 400-1500m/z with an MSe method. .. The .raw data were loaded into MassLynx4.1 (Waters Corp., Milford, MA, USA) and processed with Chick Chorioallantoic Membrane Assay:Article Title: Processing and Structure of the Lantibiotic Peptide Nso From the Human Gut Bacterium Blautia obeum A2-162 analysed by Mass Spectrometry Article Snippet: .. However, as shown in Fig. S4c and Table 1, after deconvolution a series of dehydration and CAM modification states of both preNsoA1 and preNsoA2/3 can be assigned A2/3 7 dehydrations noCAM A2/3 8 dehydrations noCAM A2/3 7 dehydrations 1 CAM A2/3 6 dehydrations 1 CAM A2/3 5 dehydrations 1 CAM A2/3 5 dehydrations 2 CAM A1 5 dehydrations 3 CAM A2/3 5 dehydrations 3 CAM A2/3 4 dehydrations 3 CAM A1 2 dehydrations 1 CAM A2/3 6 dehydrations noCAM A2/3 4 dehydrations 2 CAM ifr000361cg_clospulldown, big elu2, shrt grad IAA mass 5520 5540 5560 5580 5600 5620 5640 5660 5680 5700 5720 5740 5760 5780 5800 5820 5840 5860 5880 5900 5920 5940 5960 5980 % 0 100 160325_05 158 (2.807) 1: TOF MS ES+ 5.09e55785.8984 5592.8760 5574.8135 5572.9180 5563.7412 5506.7593 5668.92245650.9053 5598.9419 5782.8970 5725.9556 5684.9263 5860.9360 5789.9009 5802.9141 5845.9600 5839.9795 5879.0850 5879.9902 5926.9731 5971.0195 A2-8H2O A2-7H2O A1-5H2O+3 CAM Supplementary Figure S4c: Spectrum of IAA treated preNsoA peptide deconvoluted from a selected range of isotope patterns using the Modification:Article Title: Processing and Structure of the Lantibiotic Peptide Nso From the Human Gut Bacterium Blautia obeum A2-162 analysed by Mass Spectrometry Article Snippet: .. However, as shown in Fig. S4c and Table 1, after deconvolution a series of dehydration and CAM modification states of both preNsoA1 and preNsoA2/3 can be assigned A2/3 7 dehydrations noCAM A2/3 8 dehydrations noCAM A2/3 7 dehydrations 1 CAM A2/3 6 dehydrations 1 CAM A2/3 5 dehydrations 1 CAM A2/3 5 dehydrations 2 CAM A1 5 dehydrations 3 CAM A2/3 5 dehydrations 3 CAM A2/3 4 dehydrations 3 CAM A1 2 dehydrations 1 CAM A2/3 6 dehydrations noCAM A2/3 4 dehydrations 2 CAM ifr000361cg_clospulldown, big elu2, shrt grad IAA mass 5520 5540 5560 5580 5600 5620 5640 5660 5680 5700 5720 5740 5760 5780 5800 5820 5840 5860 5880 5900 5920 5940 5960 5980 % 0 100 160325_05 158 (2.807) 1: TOF MS ES+ 5.09e55785.8984 5592.8760 5574.8135 5572.9180 5563.7412 5506.7593 5668.92245650.9053 5598.9419 5782.8970 5725.9556 5684.9263 5860.9360 5789.9009 5802.9141 5845.9600 5839.9795 5879.0850 5879.9902 5926.9731 5971.0195 A2-8H2O A2-7H2O A1-5H2O+3 CAM Supplementary Figure S4c: Spectrum of IAA treated preNsoA peptide deconvoluted from a selected range of isotope patterns using the Glycoproteomics:Article Title: Highly sensitive glycosylamine labelling of O-glycans using non-reductive β-elimination. Article Snippet: When developing biopharmaceuticals, glycans are the most important posttranslational protein modifications that must be addressed because they affect the between-protein interactions that maintain homeostasis.. The glycan profile may be defined as a critical quality attribute of a biopharmaceutical.. Comprehensive analysis of protein glycosylation must overcome challenges such as the release, labelling, separation and detection of O-glycans. |